Search

This piece offers a space for critical debate and reflection on the methodological and epistemological foundations that underpin feminist research on conflict, violence and peace. Taking stock of the variety of approaches and theoretical standpoints, we examine the (feminist) politics of knowledge production in academia and its limitations. We discuss how ontological and epistemological assumptions shape what counts as (feminist) academic knowledge and what is considered to be possible in (policy) practice. The article makes three contributions. First, we argue that the production of knowledge within disciplinary boundaries, and in particular, International Relations, is closely related to the discipline's history of positivism and exclusion. Second, to counter that, we propose a close engagement with Black and decolonial feminist methods of feeling-knowing, storytelling and collaboration. Third, we highlight that embracing uncertainty means accepting incommensurability and heterogeneity, as well as a shift away from the urge to accumulate knowledge towards paying attention to the process of co-constructing it., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2024.)

Objective: To assess the effectiveness and safety of using 5-azacitidine to treat myelodysplastic syndromes., Methods: Review of medical records of patients who received 5-azacitidine 75mg/m(2) subcutaneously for during 7 days every 28 days in twelve cycles as compassionate use. We evaluated the objective response, clinical improvement and time to disease progression. We recorded adverse reactions described in the medical history., Results: Six patients were candidates for treatment with 5-azacitidine. Three cases were evaluated over the study period. Most remained in partial response or better after the study, and no longer needed transfusions. In one patient, the treatment appeared to delay progression to leukaemia., Conclusions: 5-Azacitidine might be considered an effective and relatively safe drug, and may have contributed to controlling peripheral cytopenias, improving the quality of life and delaying progression to leukaemia. Additional studies with more patients are needed to support these results., (Copyright © 2009 SEFH. Published by Elsevier Espana. All rights reserved.)

Objective: To identify the different types of cytostatic prescription errors in adult and paediatric oncohematological patients in our hospital and to propose strategies for improvement., Methods: Longitudinal, prospective, observational study in which prescriptions for antineoplastics from the haematology and paediatric oncohaematology departments were validated over a 15-month period. The types of error were classified in accordance with the terminology and taxonomy published by Otero and cols in the document "Medication errors: standardisation of terminology and classification". Eleven variables were recorded. Amongst other parameters, the following were determined: percentage of overall error, percentage of error in type of prescription, percentage of service error, percentage of pharmaceutical intervention and level of acceptance., Results: A total of 92 errors were recorded which corresponded to 1.4% of the total prescriptions. The most significant errors were: incorrect dose (28.2%), incorrect duration (21.7%), incorrect volume and/or inadequate vehicle (16.3%), and in one case a prescription was made up where the patient was allergic to the specific cytostatic drug prescribed. 81.8% of prescription errors were made manually. In the haematology department a 0.9% error was recorded, as was a 3.5% error in paediatric oncohaematology. Both the rate of pharmaceutical intervention and its level of acceptance were 100%.